Aan dit artikel is enkele uren gewerkt. Vertalen, interpreteren, relevante informatie erbij zoeken enz. Als u ons werk en kanker-actueel.nl waardeert dan wilt u ons misschein ondersteunen met een donatie, of direct al of niet anoniem op RABO 37.29.31.138 t.n.v. Stichting Gezondheid Actueel in Amersfoort.
Onze IBANcode is NL79 RABO 0372 9311 38
19 mei 2024: lees ook dit artikel: https://kanker-actueel.nl/geaccrediteerde-online-scholing-sport-bewegen-en-het-darmmicrobioom-voor-artsen-en-therapeuten-data-23-mei-2024-en-4-juni-2024-deelname-is-gratis.html
7 augustus 2023:
Zie ook dit artikel: https://kanker-actueel.nl/aerobics-naast-chemotherapie-heeft-een-positief-effect-op-door-chemo-veroorzaakte-neuropathie-en-een-bewegingsprogramma-zou-altijd-gestimuleerd-moeten-worden.html
13 september 2017: Bron: ASCO 2017
Elke kankerpatient zou naast een behandeling tegen kanker een gericht bewegingsprogramma plus psychologische ondersteuning moeten worden voorgeschreven.
Stellen de onderzoekers na een grote reviewstudie. Lichamelijke beweging en sporten kan vermoeidheid gerelateerd aan kanker voorkomen en herstellen. Het effect van gerichte bewegingsoefeningen was zo groot dat de onderzoekers er dus voor pleiten om iedere kankerpatiënt een gericht bewegingsprogramma plus psychologische begeleiding voor te schrijven / adviseren.
Dit blijkt uit een grote reviewstudie van samen 113 gerandomiseerde studies bij totaal meer dan 11.000 patiënten. In deze studie werden vier manieren van aanpak vergeleken: oefeningen / bewegen, oefeningen / bewegen plus psychologische ondersteuning, alleen psychologische ondersteuning en medicijnen / farmaceutische middelen.
Uit de studie kwam heel sterk naar voren dat gerichte bewegingsoefeningen een groot effect hebben de vermindering van aan kanker gerelateerde vermoeidheid:
Gerichte bewegingsoefeningen (WES, 0.30; 95% CI, 0.25–0.36; P < .001), en
Psychologische ondersteuning (WES, 0.27; 95% CI, 0.21–0.33; P < .001), en
Gerichte bewegingsoefeningen plus psychologische ondersteuning (WES, 0.26; 95% CI, 0.13–0.38; P < .001) verbeterden aan kanker gerelateerde vermoeidheid gedurende en na een behandeling. terwijl een farmaceutische aanpak met medicijnen geen verbetering gaf te zien. (WES, 0.09; 95% CI, 0.00–0.19; P = .05).
Figure 2
Forest Plot of Weighted Effect Sizes (WESs)
Overall WES across all interventions, exercise interventions, psychological interventions, exercise plus psychological interventions, and pharmaceutical interventions. Different sizes of markers indicate weight.
Een andere studie: Effect of exercise on quality of life (QoL) in 198 older patients with cancer: A URCC NCORP nationwide RCT. uitgevoerd bij oudere mensen, met vooral borstkanker die allemaal chemotherpaie kregen of hadden gehad gaf vergelijkbare resultaten te zien. Waarbgij opvalt dat bewwegen een effect heeft op bepaalde biomarkers, zoals die van ontstekingsmarkers en ook van DNA markers.
Results: Median age was 66.7 ± 2.3 years, 92% were female and 77% had breast cancer. In terms of chemotherapy, 3-week and 2-week regimens were used for 72% and 28%, respectively. EXCAP group had better social (p=0.02), emotional (p=0.04) and physical (p=0.03) well-being post-intervention than the C group. There was also a positive trend for improvement in functional, cognitive and overall well-being (Table 1). In the EXCAP group, improved social well-being was associated with decreases in the pro-inflammatory cytokine, IL-8 (r=0.30, p=0.03).
| QoL Domains | | EXCAP (mean ± SD) | Control (mean ± SD) | P-value |
|---|
| FACT-G |
Overall |
85.5 ± 15.6 |
82.1 ± 17.2 |
0.46 |
|
Social |
25.4 ± 4.3 |
23.7 ± 5.5 |
0.02 |
|
Emotional |
20.5 ± 3.0 |
19.9 ± 3.7 |
0.04 |
|
Physical |
20.4 ± 6.3 |
19.9 ± 5.5 |
0.03 |
|
Functional |
19.3 ± 6.0 |
18.7 ± 6.1 |
0.49 |
| Fact-Cog |
Cognition |
27.3 ± 5.8 |
25.5 ± 7.0 |
0.06 |
In deze studie: Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep problems, Depression, Pain, Anxiety, and Physical Dysfunction: A Review wordt beschreven wat de effecten van chemo enz. zijn en wat bepaalde aanpak daaraan kan bijdragen om de bijwerkingen te voorkomen en verminderen
Zie onderstaande grafiek:
Figure 1
The 5 A’s of Applied Exercise Oncology
Medscape schreef over de reviewstudie een mooi samenvattend artikel: New Biomarker Data Provide Even More Support for Exercise Against Cancer-Related Fatigue
Zij gebruikten voor dat artikel de volgende referenties. daaronder het abstract van de reviewstudie
References
-
Mustian KM, Alfano CM, Heckler C, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol. 2017;3:961-968. doi: 10.1001/jamaoncol.2016.6914.
-
Mustian KM, Peoples AR, Peppone LJ, et al. Effect of exercise on novel biomarkers of muscle damage and cancer-related fatigue: A nationwide URCC NCORP RCT in 350 patients with cancer. Program and abstracts of the 2017 American Society of Clinical Oncology Annual Meeting; June 2-6, 2017; Chicago, Illinois. Abstract 10020.
-
Chae JW, Chua PS, Ng T, et al. Mitochondrial DNA content in peripheral blood as a biomarker for cancer-related fatigue in early-stage breast cancer patients: A prospective cohort study. Program and abstracts of the 2017 American Society of Clinical Oncology Annual Meeting; June 2-6, 2017; Chicago, Illinois. Abstract 10018.
-
Loh KP, Mohile SG, Cole C, et al. Effect of exercise on quality of life (QoL) in 198 older patients with cancer: A URCC NCORP nationwide RCT. Program and abstracts of the 2017 American Society of Clinical Oncology Annual Meeting; June 2-6, 2017; Chicago, Illinois. Abstract 10019.
Hier het abstract van de reviewstudie uit JAMA:
Exercise and psychological interventions are effective for reducing Cancer Related Fatigue - CRF during and after cancer treatment, and they are significantly better than the available pharmaceutical options. Clinicians should prescribe exercise or psychological interventions as first-line treatments for CRF.
JAMA Oncol. Author manuscript; available in PMC 2017 Aug 15.
Published in final edited form as:
PMCID: PMC5557289
NIHMSID: NIHMS892615
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue A Meta-analysis
Karen M. Mustian, PhD, MPH,
Catherine M. Alfano, PhD,
Charles Heckler, PhD, MS,
Amber S. Kleckner, PhD,
Ian R. Kleckner, PhD,
Corinne R. Leach, PhD,
David Mohr, PhD,
Oxana G. Palesh, PhD, MPH,
Luke J. Peppone, PhD, MPH,
Barbara F. Piper, PhD,
John Scarpato, MA,
Tenbroeck Smith, MA,
Lisa K. Sprod, PhD, MPH, and
Suzanne M. Miller, PhD
Abstract
IMPORTANCE
Cancer-related fatigue (CRF) remains one of the most prevalent and troublesome adverse events experienced by patients with cancer during and after therapy.
OBJECTIVE
To perform a meta-analysis to establish and compare the mean weighted effect sizes (WESs) of the 4 most commonly recommended treatments for CRF—exercise, psychological, combined exercise and psychological, and pharmaceutical—and to identify independent variables associated with treatment effectiveness.
DATA SOURCES
PubMed, PsycINFO, CINAHL, EMBASE, and the Cochrane Library were searched from the inception of each database to May 31, 2016.
STUDY SELECTION
Randomized clinical trials in adults with cancer were selected. Inclusion criteria consisted of CRF severity as an outcome and testing of exercise, psychological, exercise plus psychological, or pharmaceutical interventions.
DATA EXTRACTION AND SYNTHESIS
Studies were independently reviewed by 12 raters in 3 groups using a systematic and blinded process for reconciling disagreement. Effect sizes (Cohen d) were calculated and inversely weighted by SE.
MAIN OUTCOMES AND MEASURES
Severity of CRF was the primary outcome. Study quality was assessed using a modified 12-item version of the Physiotherapy Evidence-Based Database scale (range, 0–12, with 12 indicating best quality).
RESULTS
From 17 033 references, 113 unique studies articles (11525 unique participants; 78% female; mean age, 54 [range, 35–72] years) published from January 1, 1999, through May 31, 2016, had sufficient data. Studies were of good quality (mean Physiotherapy Evidence-Based Database scale score, 8.2; range, 5–12) with no evidence of publication bias. Exercise (WES, 0.30; 95% CI, 0.25–0.36; P < .001), psychological (WES, 0.27; 95% CI, 0.21–0.33; P < .001), and exercise plus psychological interventions (WES, 0.26; 95% CI, 0.13–0.38; P < .001) improved CRF during and after primary treatment, whereas pharmaceutical interventions did not (WES, 0.09; 95% CI, 0.00–0.19; P = .05). Results also suggest that CRF treatment effectiveness was associated with cancer stage, baseline treatment status, experimental treatment format, experimental treatment delivery mode, psychological mode, type of control condition, use of intention-to-treat analysis, and fatigue measures (WES range, −0.91 to 0.99). Results suggest that the effectiveness of behavioral interventions, specifically exercise and psychological interventions, is not attributable to time, attention, and education, and specific intervention modes may be more effective for treating CRF at different points in the cancer treatment trajectory (WES range, 0.09–0.22).
CONCLUSIONS AND RELEVANCE
Exercise and psychological interventions are effective for reducing CRF during and after cancer treatment, and they are significantly better than the available pharmaceutical options. Clinicians should prescribe exercise or psychological interventions as first-line treatments for CRF.
References
1.
Patrick DL, Ferketich SL, Frame PS, et al. National Institutes of Health State-of-the-Science Panel National Institutes of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15–17, 2002. J Natl Cancer Inst. 2003;95(15):1110–1117. [PubMed]2.
Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment. Support Care Cancer. 2008;16(7):791–801. [PubMed]3.
Kuhnt S, Ernst J, Singer S, et al. Fatigue in cancer survivors—prevalence and correlates. Onkologie. 2009;32(6):312–31. [PubMed]4.
Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002;38(1):27–43. [PubMed]5.
Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004;(32):40–50. [PubMed]6.
Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue. Oncologist. 2007;12(suppl 1):4–10. [PubMed]7.
Minton O, Stone P. How common is fatigue in disease-free breast cancer survivors? Breast Cancer Res Treat. 2008;112(1):5–13. [PubMed]8.
Prue G, Rankin J, Allen J, Gracey J, Cramp F. Cancer-related fatigue: a critical appraisal. Eur J Cancer. 2006;42(7):846–863. [PubMed]9.
Andrykowski MA, Donovan KA, Laronga C, Jacobsen PB. Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer. 2010;116(24):5740–5748. [PMC free article] [PubMed]10.
Cella D, Davis K, Breitbart W, Curt G, Fatigue Coalition Cancer-related fatigue. J Clin Oncol. 2001;19(14):3385–3391. [PubMed]11.
Bower JE, Ganz PA, Desmond KA, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006;106(4):751–758. [PubMed]12.
Carpenter JS, Elam JL, Ridner SH, Carney PH, Cherry GJ, Cucullu HL. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum. 2004;31(3):591–598. [PubMed]13.
Stepanski EJ, Walker MS, Schwartzberg LS, Blakely LJ, Ong JC, Houts AC. The relation of trouble sleeping, depressed mood, pain, and fatigue in patients with cancer. J Clin Sleep Med. 2009;5(2):132–136. [PMC free article] [PubMed]14.
Roscoe JA, Kaufman ME, Matteson-Rusby SE, et al. Cancer-related fatigue and sleep disorders. Oncologist. 2007;12(suppl 1):35–42. [PubMed]15.
Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors. J Clin Oncol. 2000;18(4):743–753. [PubMed]16.
Alexander S, Minton O, Andrews P, Stone P. A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer. 2009;45(3):384–392. [PMC free article] [PubMed]17.
Donovan KA, Jacobsen PB. Fatigue, depression, and insomnia. Semin Oncol Nurs. 2007;23(2):127–135. [PubMed]18.
Beck SL, Dudley WN, Barsevick A. Pain, sleep disturbance, and fatigue in patients with cancer. Oncol Nurs Forum. 2005;32(3):542. [PubMed]19.
Curt GA, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients. Oncologist. 2000;5(5):353–360. [PubMed]21.
Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev. 2009;(1):CD006953. [PubMed]22.
Peuckmann V, Elsner F, Krumm N, Trottenberg P, Radbruch L. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev. 2010;(11):CD006788. [PubMed]23.
Velthuis MJ, Agasi-Idenburg SC, Aufdemkampe G, Wittink HM. The effect of physical exercise on cancer-related fatigue during cancer treatment. Clin Oncol (R Coll Radiol) 2010;22(3):208–221. [PubMed]24.
Speck RM, Courneya KS, Mâsse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors. J Cancer Surviv. 2010;4(2):87–100. [PubMed]25.
Brown JC, Huedo-Medina TB, Pescatello LS, Pescatello SM, Ferrer RA, Johnson BT. Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors. Cancer Epidemiol Biomarkers Prev. 2011;20(1):123–133. [PubMed]26.
van Vulpen JK, Peeters PH, Velthuis MJ, van der Wall E, May AM. Effects of physical exercise during adjuvant breast cancer treatment on physical and psychosocial dimensions of cancer-related fatigue. Maturitas. 2016;85:104–111. [PubMed]27.
Meneses-Echávez JF, González-Jiménez E, Ramírez-Vélez R. Effects of supervised exercise on cancer-related fatigue in breast cancer survivors. BMC Cancer. 2015;15:77. [PMC free article] [PubMed]28.
Meneses-Echavez JF, Gonzalez-Jimenez E, Ramirez-Velez R. Effects of supervised multimodal exercise interventions on cancer-related fatigue. BioMed Res Int. 2015;2015:328–636. [PMC free article] [PubMed]29.
Puetz TW, Herring MP. Differential effects of exercise on cancer-related fatigue during and following treatment. Am J Prev Med. 2012;43(2):e1–e24. [PubMed]30.
Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2012;(11):CD006145. [PubMed]31.
Duijts SF, Faber MM, Oldenburg HS, van Beurden M, Aaronson NK. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors. Psychooncology. 2011;20(2):115–126. [PubMed]32.
Jacobsen PB, Donovan KA, Vadaparampil ST, Small BJ. Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol. 2007;26(6):660–667. [PMC free article] [PubMed]33.
Du S, Hu L, Dong J, et al. Patient education programs for cancer-related fatigue: a systematic review. Patient Educ Couns. 2015;98(11):1308–1319. [PubMed]34.
Minton O, Richardson A, Sharpe M, Hotopf M, Stone P. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst. 2008;100(16):1155–1166. [PubMed]35.
Gong S, Sheng P, Jin H, et al. Effect of methylphenidate in patients with cancer-related fatigue. PLoS One. 2014;9(1):e84391. [PMC free article] [PubMed]36.
Mitchell SA, Hoffman AJ, Clark JC, et al. Putting evidence into practice. Clin J Oncol Nurs. 2014;18(suppl):38–58. [PubMed]37.
Bower JE, Bak K, Berger A, et al. American Society of Clinical Oncology Screening, assessment, and management of fatigue in adult survivors of cancer. J Clin Oncol. 2014;32(17):1840–1850. [PMC free article] [PubMed]39.
Moher D, Altman DG, Liberati A, Tetzlaff J. PRISMA statement. Epidemiology. 2011;22(1):128. [PubMed]40.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269. W264. [PubMed]41.
Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue. Psychol Bull. 2008;134(5):700–741. [PubMed]42.
Verhagen AP, de Vet HC, de Bie RA, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998;51(12):1235–1241. [PubMed]43.
Bhogal SK, Teasell RW, Foley NC, Speechley MR. The PEDro scale provides a more comprehensive measure of methodological quality than the Jadad scale in stroke rehabilitation literature. J Clin Epidemiol. 2005;58(7):668–673. [PubMed]44.
Moseley AM, Herbert RD, Sherrington C, Maher CG. Evidence for physiotherapy practice: a survey of the Physiotherapy Evidence Database (PEDro) Aust J Physiother. 2002;48(1):43–49. [PubMed]45. Hedges LV. A random effects model for effect sizes. Psychol Bull. 1983;93(2):388–395.
46. Higgins JPT, Green S. Cochrane Collaboration: Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ: Wiley-Blackwell; 2008.
47. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-analysis. Chichester, England: John Wiley & Sons; 2009.
48. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1–48.
49.
Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM. The revised Piper Fatigue Scale. Oncol Nurs Forum. 1998;25(4):677–684. [PubMed]50.
Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients. Cancer. 1999;85(5):1186–1196. [PubMed]51.
Stein KD, Martin SC, Hann DM, Jacobsen PB. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract. 1998;6(3):143–152. [PubMed]54. Duval S, Tweedie R. The trim and fill method. In: Rothstein HR, Sutton AJ, Borenstein M, editors. Publication Bias in Meta-analysis: Prevention, Assessment and Adjustments. Chichester, England: Wiley; 2005.
55.
Rosenberg MS. The file-drawer problem revisited. Evolution. 2005;59(2):464–468. [PubMed]56.
Saint-Raymond A, Hill S, Martines J, Bahl R, Fontaine O, Bero L. CONSORT 2010. Lancet. 2010;376(9737):229–230. [PubMed]57.
Schulz KF, Altman DG, Moher D, CONSORT Group CONSORT 2010 Statement. J Clin Epidemiol. 2010;63(8):834–840. [PubMed]
bewegen, sporten, chronische vermoeidheid, kankerpatienten, ex-kankerpatienten, complementair, literatuurlijsten
Gerelateerde artikelen
Plaats een reactie ...
Reageer op "Bewegen en sporten voorkomt en herstelt ernstige vermoeidheid bij kankerpatienten blijkt uit grote studies. Iedere kankerpatient zou een bewegingsprogramma moeten worden voorgeschreven aldus de onderzoekers."